2.53k followers • 25 symbols Watchlist by Yahoo Finance
Follow this list to discover and track stocks that were removed from most watchlists by Yahoo Finance Users. This list is generated daily and limited to the top 30 stocks that meet the criteria.
Gilead Sciences, Inc.
Constellation Brands, Inc.
Teva Pharmaceutical Industries Limited
Newell Brands Inc.
Canopy Growth Corporation
EQM Midstream Partners, LP
Parsley Energy, Inc.
AVITA Therapeutics, Inc.
Amarin Corporation plc
Cronos Group Inc.
Nutanix (NASDAQ: NTNX), a leader in enterprise cloud computing, today announced that it will host a conference call to discuss the changing future of work by building End User Computing (EUC) solutions on Nutanix to enable secured access to applications, desktop, and data from any device, any time, and any location.
AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today preliminary unaudited results for the fourth quarter and full year ended June 30, 2020, together with a company update.
Gilead Sciences Inc <GILD.O> plans to make more of its drug remdesivir available for Germany and Europe from autumn and will decide how much each country gets based on the rate of infection, the drugmaker's Germany boss told a German magazine. Bettina Bauer, managing director of Gilead in Germany, told WirtschaftsWoche the U.S. drugmaker can increase its worldwide monthly production from currently 190,000 treatment cycles to 2 million treatment cycles in December.
The company said the trial, which will enroll about 60 healthy Americans aged between 18 and 45, will test the drug particularly in those cases where the disease has not progressed to require hospitalization. The drug is currently used intravenously and an inhaled formulation would be given through a nebulizer, which could potentially allow for easier administration outside hospitals. Remdesivir was granted emergency use authorization in the United States to treat severe cases of COVID-19 in patients who are hospitalized.
Alcoa Corporation (NYSE:AA) ("Alcoa") announced today that Alcoa Nederland Holding B.V. (the "issuer"), a wholly-owned subsidiary of Alcoa, has priced an offering of $750,000,000 aggregate principal amount of 5.500% senior notes due 2027. The sale of the notes is expected to be completed on July 13, 2020, subject to customary closing conditions.
The pharma stock collapsed on the threat of generic competition for a drug that launched in December 2019, but the move may have been a bit of an overreaction.
Alcoa (AA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
It pays to check the valuation before investing because it isn't always the best companies that have upside potential.
The biotech sector remains in focus with updates on coronavirus treatments and other pipeline updates.
LabCorp (LH) claims this to be the first digital COVID-19 service that physicians can use to remotely diagnose patients before any surgery or procedure.
Both cannabis markets are drawing attention. How are these two companies approaching these segments?
Alcoa Corporation (NYSE:AA) ("Alcoa") announced today a proposed offering of senior notes (the "notes") by Alcoa Nederland Holding B.V. (the "issuer"), a wholly-owned subsidiary of Alcoa.
Alcoa Corporation (NYSE: AA) today released preliminary second quarter 2020 results that show the Company’s cash balance rising to more than $950 million with improved productivity and continued stability in operations during the coronavirus pandemic.
Cleveland-Cliffs Inc. (NYSE: CLF) announced today it will be reporting second-quarter 2020 financial results before the U.S.-market open on Thursday, July 30, 2020.
Nutanix (NASDAQ: NTNX), a leader in enterprise cloud computing, today announced that Birmingham City Council’s Information, Technology and Digital Service (IT&D) will team up with Nutanix to migrate its legacy hardware to a hybrid cloud infrastructure. The new infrastructure will be based on Nutanix’s highly scalable hyperconverged infrastructure (HCI) software with its integrated AHV hypervisor and central management console, Prism. It will also leverage other cloud products including Nutanix Beam, Calm and Flow.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced data presented at the 23rd International AIDS Conference (AIDS 2020: Virtual) evaluating the impact of COVID-19 shelter-in-place orders (SIPOs) and PrEP utilization on HIV prevention strategies and associated risk behaviors. Findings presented included results from an online survey conducted by The American Academy of HIV Medicine (AAHIVM) to understand potential changes in behavior among pre-exposure prophylaxis (PrEP) users and prescribers in the United States during the height of COVID-19 SIPOs. There were 598 total respondents – 409 PrEP users and 189 PrEP prescribers. While most prescribers (90 percent) reported recommending no change in PrEP regimen, about one-third (33 percent) of PrEP users discontinued therapy voluntarily, mostly (85 percent) due to low perceived HIV risk associated with decreased sexual activity. Only 8 percent of those users who discontinued PrEP cited inability to access PrEP medications. Nearly all prescribers (95 percent) were able to successfully prescribe PrEP despite limitations caused by SIPOs.
Gilead Sciences (GILD) closed the most recent trading day at $76.42, moving -0.44% from the previous trading session.
Zacks.com featured highlights include: Bristol-Myers Squibb, Vale, Gilead Sciences, Kroger and Delek Logistics Partners
Oracle announced today the award of a Framework Agreement for the provision of secure cloud services to the Government of Canada. This agreement gives Oracle's Canadian federal government customers the ability to securely store, manage and process sensitive data and applications in Oracle Cloud Infrastructure.
LiveXLive Media (NASDAQ: LIVX) ("LiveXLive"), a global platform for live stream and on-demand audio, video and podcast content in music, comedy, and pop culture, announced today that the Midwest's largest all-electronic music festival -- Spring Awakening Music Festival (SAMF) -- will return home to the City of Chicago for its 10 year anniversary in 2021. The event will be presented by Corona Electric Beach as part of a multi-year deal that included SAMF 2020 and its first virtual experience on July 4 and 5, 2020. LiveXLive also announced today that SAMF's 10th Anniversary Event will include a virtual live stream component on the heels of the success of this past weekend's virtual SAMF.
iQIYI, Inc. (NASDAQ: IQ) ("iQIYI" or the "Company"), an innovative market-leading online Chinese entertainment service company, is pleased to announce that Vivian Wang, the Company's Chief Marketing Officer and President of its New Consumer Business Group, has been included in Campaign Asia's 2020 Asia-Pacific Power List, which recognizes Asia-Pacific's 50 most influential and purposeful marketers, for her achievements and iQIYI's continued success in entertainment marketing under her leadership.
Gilead Sciences Inc plans to make more of its drug remdesivir available for Germany and Europe from the Fall and will decide how much each country gets based on the rate of infection, the drugmaker's Germany boss told a German magazine. Bettina Bauer, German managing director of Gilead, told WirtschaftsWoche the U.S. drugmaker can increase its worldwide monthly production from currently 190,000 treatment cycles to two million treatment cycles in December. Remdesivir is currently the only drug granted a conditional marketing authorisation by the EU for its use in COVID-19 patients.
Rating Action: Moody's affirms seven and downgrades four classes of JPMBB 2013- C14. Global Credit Research- 08 Jul 2020. Approximately $679 million of structured securities affected.